Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Study of Bispecific T Cell Engager (BRiTE) in Patients With Newly Diagnosed or Recurrent Glioblastoma

NCT04903795 is registered in ClinicalTrials.gov with Mustafa Khasraw, MBChB, MD, FRCP, FRACP as lead sponsor.

NCT NCT04903795
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04903795 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Study of Bispecific T Cell Engager (BRiTE) in Patients With Newly Diagnosed or Recurrent Glioblastoma
Lead sponsor
Mustafa Khasraw, MBChB, MD, FRCP, FRACP
Phase
Phase 1
Overall status
Recruiting
Start date
August 17, 2026
Completion date
December 30, 2027
Enrollment
18 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

newly diagnosed glioblastoma, recurrent glioblastoma